0001209191-21-007944.txt : 20210204
0001209191-21-007944.hdr.sgml : 20210204
20210204204343
ACCESSION NUMBER: 0001209191-21-007944
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210202
FILED AS OF DATE: 20210204
DATE AS OF CHANGE: 20210204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBIN HOWARD W
CENTRAL INDEX KEY: 0001206869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24006
FILM NUMBER: 21593002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS
CENTRAL INDEX KEY: 0000906709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943134940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 4154825300
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC
DATE OF NAME CHANGE: 19980723
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS
DATE OF NAME CHANGE: 19940303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-02
0
0000906709
NEKTAR THERAPEUTICS
NKTR
0001206869
ROBIN HOWARD W
C/O NEKTAR THERAPEUTICS
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO
CA
94158
1
1
0
0
President & CEO
Common Stock
2021-02-02
4
M
0
150000
8.80
A
608693
D
Common Stock
2021-02-02
4
S
0
139500
19.69
D
469193
D
Common Stock
2021-02-02
4
S
0
9900
20.84
D
459293
D
Common Stock
2021-02-02
4
S
0
600
21.59
D
458693
D
Common Stock
2021-02-03
4
M
0
75000
8.80
A
533693
D
Common Stock
2021-02-03
4
M
0
75000
8.80
A
608693
D
Common Stock
2021-02-03
4
S
0
150000
19.72
D
458693
D
Common Stock
2021-02-04
4
M
0
150000
8.80
A
608693
D
Common Stock
2021-02-04
4
S
0
91863
20.10
D
516830
D
Common Stock
2021-02-04
4
S
0
58137
20.58
D
458693
D
Common Stock
410
I
by spouse
Stock Option
8.80
2021-02-02
4
M
0
150000
0.00
D
2017-02-06
2021-02-05
Common Stock
150000
75000
D
Stock Option
8.80
2021-02-03
4
M
0
75000
0.00
D
2017-02-06
2021-02-05
Common Stock
75000
0
D
Stock Option
8.80
2021-02-03
4
M
0
75000
0.00
D
2017-02-06
2021-02-05
Common Stock
75000
150000
D
Stock Option
8.80
2021-02-04
4
M
0
150000
0.00
D
2017-02-06
2021-02-05
Common Stock
150000
0
D
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021.
This transaction was executed in multiple trades at prices ranging from $19.41 to $20.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $20.42 to $21.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $21.43 to $21.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $19.26 to $19.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $19.50 to $20.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $20.51 to $20.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
Mark A. Wilson, Attorney-in-Fact
2021-02-04